Table of Contents
Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List Of Secondary Sources
1.8 Objectives
1.8.1 Objective 1:
1.8.2 Objective 2:
1.8.3 Market Estimation For Serum-Free Media Market
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Market Variables, Trends, And Scope
3.1 Market Segmentation And Scope
3.2 Market Lineage Outlook
3.2.1 Parent Market Outlook
3.2.2 Related/Ancillary Market Outlook
3.3 Penetration And Growth Prospect Mapping
3.4 Market Dynamics
3.4.1 Market Drivers Analysis
3.4.1.1 Expansion Of Biosimilars And Biologics
3.4.1.2 Growth In Stem Cell Research
3.4.1.3 Emerging Cell Culture Technologies For Cell-Based Vaccines
3.4.2 Market Restraint Analysis
3.4.2.1 Ethical Issues Concerning The Use Of Animal-Derived Products
3.4.2.2 Stringent Regulatory Guidelines
3.4.3 Market Opportunity Analysis
3.4.3.1 Increasing Investments By Key Market Players
3.5 Market Trends And Outlook
3.6 Business Environment Analysis
3.6.1 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
3.6.2 Porter’s Five Forces Analysis
3.7 Covid-19 Impact Analysis
Chapter 4 Product Business Analysis
4.1 Serum-Free Media Market: Product Movement Analysis, 2022 & 2030
4.2 Cho Media
4.2.1 Global Cho Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.3 Hek 293 Media
4.3.1 Global Hek 293 Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.4 Bhk Medium
4.4.1 Global Bhk Medium Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.5 Vero Medium
4.5.1 Global Vero Medium Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.6 Stem Cell Medium
4.6.1 Global Stem Cell Medium Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.7 Other Serum-Free Media
4.7.1 Global Other Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 5 Type Business Analysis
5.1 Serum-Free Media Market: Type Movement Analysis, 2022 & 2030
5.2 Liquid Media
5.2.1 Global Liquid Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.3 Semisolid & Solid Media
5.3.1 Global Semi-Solid & Solid Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 6 Application Business Analysis
6.1 Serum-Free Media Market: Application Movement Analysis, 2022 & 2030
6.2 Biopharmaceutical Production
6.2.1 Global Biopharmaceutical Production Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.2 Monoclonal Antibodies
6.2.2.1 Global Monoclonal Antibodies Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.3 Vaccines Production
6.2.3.1 Global Vaccines Production Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.2.4 Other Therapeutic Proteins
6.2.4.1 Global Other Therapeutic Proteins Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3 Tissue Engineering & Regenerative Medicine
6.3.1 Global Tissue Engineering & Regenerative Medicine Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 7 End User Business Analysis
7.1 Serum-Free Media Market: End User Movement Analysis, 2022 & 2030
7.2 Pharmaceutical & Biotechnology Companies
7.2.1 Global Pharmaceutical & Biotechnology Companies Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.3 Research & Academic Institutes
7.3.1 Global Research & Academic Institutes Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.4 Other End User
7.4.1 Global Other End User Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 8 Regional Business Analysis
8.1 North America
8.1.1 Swot Analysis:
8.1.1.1 North America Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.1.2 U.S.
8.1.2.1 Key Country Dynamics
8.1.2.2 Competitive Scenario
8.1.2.4 Regulatory Framework
8.1.2.5 U.S. Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.1.3 Canada
8.1.3.1 Key Country Dynamics
8.1.3.2 Competitive Scenario
8.1.3.4 Regulatory Framework
8.1.3.5 Canada Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.2 Europe
8.2.1 Swot Analysis:
8.2.1.1 Europe Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.2.2 Germany
8.2.2.1 Key Country Dynamics
8.2.2.2 Competitive Scenario
8.2.2.3 Regulatory Framework
8.2.2.4 Germany Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.2.3 U.K.
8.2.3.1 Key Country Dynamics
8.2.3.2 Competitive Scenario
8.2.3.3 Regulatory Framework
8.2.3.4 U.K. Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.2.4 France
8.2.4.1 Key Country Dynamics
8.2.4.2 Competitive Scenario
8.2.4.3 Regulatory Framework
8.2.4.4 France Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.2.5 Italy
8.2.5.1 Key Country Dynamics
8.2.5.2 Competitive Scenario
8.2.5.3 Regulatory Framework
8.2.5.4 Italy Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.2.6 Spain
8.2.6.1 Key Country Dynamics
8.2.6.2 Competitive Scenario
8.2.6.3 Regulatory Framework
8.2.6.4 Spain Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.2.7 Denmark
8.2.7.1 Key Country Dynamics
8.2.7.2 Competitive Scenario
8.2.7.3 Regulatory Framework
8.2.7.4 Denmark Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.2.8 Norway
8.2.8.1 Key Country Dynamics
8.2.8.2 Competitive Scenario
8.2.8.3 Regulatory Framework
8.2.8.4 Norway Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.2.10 Sweden
8.2.9.1 Key Country Dynamics
8.2.9.2 Competitive Scenario
8.2.9.3 Regulatory Framework
8.2.9.4 Sweden Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3 Asia Pacific
8.3.1 Swot Analysis:
8.3.1.1 Asia Pacific Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.2 Japan
8.3.2.1 Key Country Dynamics
8.3.2.2 Competitive Scenario
8.3.2.3 Regulatory Framework
8.3.2.4 Japan Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.3 China
8.3.3.1 Key Country Dynamics
8.3.3.2 Competitive Scenario
8.3.3.3 Regulatory Framework
8.3.3.4 China Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.4 India
8.3.4.1 Key Country Dynamics
8.3.4.2 Competitive Scenario
8.3.4.3 Regulatory Framework
8.3.4.4 India Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.5 South Korea
8.3.5.1 Key Country Dynamics
8.3.5.2 Competitive Scenario
8.3.5.3 Regulatory Framework
8.3.5.4 South Korea Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.6 Australia
8.3.6.1 Key Country Dynamics
8.3.6.2 Competitive Scenario
8.3.6.3 Regulatory Framework
8.3.6.4 Australia Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.7 Thailand
8.3.7.1 Key Country Dynamics
8.3.7.2 Competitive Scenario
8.3.7.3 Regulatory Framework
8.3.7.4 Thailand Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4 Latin America
8.4.1 Swot Analysis:
8.4.1.1 Latin America Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.2 Argentina
8.4.2.1 Key Country Dynamics
8.4.2.2 Competitive Scenario
8.4.2.3 Regulatory Scenario
8.4.2.4 Argentina Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.3 Brazil
8.4.3.1 Key Country Dynamics
8.4.3.2 Competitive Scenario
8.4.3.3 Regulatory Framework
8.4.3.4 Brazil Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.4 Mexico
8.4.4.1 Key Country Dynamics
8.4.4.2 Competitive Scenario
8.4.3.3 Regulatory Framework
8.4.4.4 Mexico Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5 Middle East And Africa
8.5.1 Swot Analysis:
8.5.1.1 Mea Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5.2 South Africa
8.5.2.1 Key Country Dynamics
8.5.2.2 Competitive Scenario
8.5.2.3 Reimbursement Scenario
8.5.2.4 South Africa Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5.3 Uae
8.5.3.1 Key Country Dynamics
8.5.3.2 Competitive Scenario
8.5.3.3 Regulatory Framework
8.5.3.4 Uae Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5.4 Saudi Arabia
8.5.4.1 Key Country Dynamics
8.5.4.2 Competitive Scenario
8.5.4.3 Regulatory Framework
8.5.4.4 Saudi Arabia Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5.5 Kuwait
8.5.5.1 Key Country Dynamics
8.5.5.2 Competitive Scenario
8.5.5.3 Regulatory Framework
8.5.5.4 Kuwait Serum-Free Media Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Company Categorization
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2022
9.4. Company Profiles/Listing
9.4.1 SARTORIUS AG
9.4.1.1 Overview
9.4.1.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3 Product Benchmarking
9.4.1.4 Strategic initiatives
9.4.2 DANAHER
9.4.2.1 Overview
9.4.2.2 Cytiva
9.4.2.2.1 Overview
9.4.2.3 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.4 Product Benchmarking
9.4.2.5 Strategic initiatives
9.4.3 THERMO FISHER SCIENTIFIC, INC.
9.4.3.1 Overview
9.4.3.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3 Product Benchmarking
9.4.3.4 Strategic initiatives
9.4.4 MERCK KGAA
9.4.4.1 Overview
9.4.4.1.1 Sigma-Aldrich Co. LLC
9.4.4.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3 Product Benchmarking
9.4.4.4 Strategic initiatives
9.4.5 FUJIFILM IRVINE SCIENTIFIC
9.4.5.1 Overview
9.4.5.2 Product Benchmarking
9.4.5.3 Strategic initiatives
9.4.6 LONZA
9.4.6.1 Overview
9.4.6.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3 Product Benchmarking
9.4.6.4 Strategic initiatives
9.4.7 MP BIOMEDICALS
9.4.7.1 Overview
9.4.7.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3 Product Benchmarking
9.4.8 CORNING INCORPORATED
9.4.8.1 Overview
9.4.8.2 Product Benchmarking
9.4.8.3 Strategic initiatives
9.4.9 PAN-BIOTECH
9.4.9.1 Overview
9.4.9.2 Product Benchmarking
9.4.10 R&D SYSTEMS, INC.
9.4.10.1 Overview
9.4.10.2 Product Benchmarking
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer